Published on June 27, 2020Citation: Xue F, Berklein F, Rane PB, Habib M, Lin PJ. "Patient characteristics and treatment patterns among Medicare beneficiaries initiating PCSK9 inhibitor therapy," Cardiovascular Drugs and Therapy, June 27, 2020. Journal: Cardiovascular Drugs and TherapyRead Publication
Published on May 21, 2020Citation: Forsythe S, Cohen J, Neumann P, Bertozzi SM, Kinghorn A. “The economic and public health imperatives around making potential coronavirus disease-2019 treatments available and affordable,” Value in Health, May 21, 2020.Journal: Value in HealthRead Publication
Published on May 20, 2020Citation: Cohen JT, Neumann PJ, Ollendorf DA. "Valuing and pricing Remdesivir: Should drug makers get paid for helping us get back to work?," Health Affairs Blog, May 20, 2020. Journal: Health Affairs BlogRead Publication
Published on May 19, 2020Citation: Chambers JD, Lai RC, Margaretos NM, Panzer AD, Cohen JT, Neumann PJ. "Coverage for Biosimilars vs reference products among US commercial health plans," Journal of the American Medical Association Research Letter, May 19, 2020. Journal: Journal of the American Medical AssociationRead Publication
Published on May 19, 2020Citation: Kim DD, Neumann PJ. "Analyzing the cost effectiveness of policy responses for COVID-19: The importance of capturing social consequences," Medical Decision Making Research Letter, May 19, 2020. Journal: Medical Decision Making Research LetterRead Publication
Published on May 15, 2020Citation: Olchanski N, Vest AR, Cohen JT, Denofrio D. Two-year outcomes and cost for heart failure patients following discharge from the hospital after an acute heart failure admission. International Journal of Cardiology 2020;307:109–13.Journal: International Journal of CardiologyRead Publication
Published on May 15, 2020Citation: Panzer AD, Emerson JG, D'Cruz B, Patel A, Dabak S, Isaranuwatchai W, Kim DD. "Growth and capacity for cost‐effectiveness analysis in Africa," Health Economics Letter, May 15, 2020.Journal: Health EconomicsRead Publication
Published on May 11, 2020Citation: Leech AA, Neumann PJ, Cohen JT, Jagasia M, Dusetzina SB. Balancing value with affordability: Cell immunotherapy for cancer treatment in the U.S. The Oncologist 2020.Journal: The OncologistRead Publication
Published on April 28, 2020Citation: Feng X, Kim DD, Cohen JT, Neumann PJ, Ollendorf DA. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter? International Journal of Technology Assessment in Health Care 2020;:1–8.Journal: International Journal of Technology Assessment in Health CareRead Publication
Published on April 13, 2020Citation: Chambers JD, Silver MC, Berklein FC, Cohen JT, Neumann PJ. Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs. Journal of General Internal Medicine 2020.Journal: Journal of General Internal MedicineRead Publication
